SYSTEMATIC FINANCIAL MANAGEMENT LP

Position in SUPN — Supernus Pharmaceuticals, Inc.

CIK 1085936 TEANECK, NJ

Back to SUPN Full portfolio

Position in SUPN

as of Mar 31, 2026 · filed May 13, 2026 Compact

Position Value

$19,439,522

+$4,319,491 QoQ

Shares Held

376,079

+23.6% QoQ

Ownership

0.648%

of shares outstanding

% of Portfolio

0.45%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

9 quarters on record

Voting authority Sole 58.796313530703735.ToString("F0")% Shared 0.ToString("F0")% None 41.203686469296265.ToString("F0")%

Common Shares in SUPN Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

SYSTEMATIC FINANCIAL MANAGEMENT LP holds $41,868,572 across 3 Drug Manufacturers - Specialty & Generic names. SUPN ranks #1 (46.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	SUPN	Supernus Pharmaceuticals, Inc. This page	376,079	$19,439,522
2	PRGO	PERRIGO Co plc	1,262,270	$13,556,779
3	AMPH	Amphastar Pharmaceuticals, Inc.	452,898	$8,872,271

All Filings in SUPN

Export CSV

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$19,439,522	376,079	+23.6%	Shares	Other	2026-05-13
2025-12-31	$15,120,031	304,226	+4.1%	Shares	Other	2026-02-09
2025-09-30	$13,967,105	292,260	+19.0%	Shares	Other	2025-11-13
2025-06-30	$7,739,578	245,545	+47.5%	Shares	Other	2025-08-13
2025-03-31	$5,453,006	166,504	+46.7%	Shares	Other	2025-05-14
2024-12-31	$4,104,160	113,500	+302.7%	Shares	Defined	2025-02-14
2024-09-30	$878,808	28,185	+99.8%	Shares	Defined	2024-11-14
2020-06-30	$335,112	14,110	-34.6%	Shares	Defined	2020-08-13
2020-03-31	$388,224	21,580	—	Shares	Defined	2020-05-12
No filing history on record for this holder in this stock.